Saponin Nanoparticle Adjuvants Incorporating Toll-Like Receptor Agonists Drive Distinct Immune Signatures and Potent Vaccine Responses.
Ou BS, Baillet J, Filsinger Interrante MV, Adamska JZ, Zhou X, Saouaf OM, Yan J, Klich JH, Jons CK, Meany EL, Valdez AS, Carter L, Pulendran B, King NP, Appel EA.
Ou BS, et al. Among authors: baillet j.
bioRxiv [Preprint]. 2024 Jun 27:2023.07.16.549249. doi: 10.1101/2023.07.16.549249.
bioRxiv. 2024.
PMID: 37577608
Free PMC article.
Updated.
Preprint.